Patents Assigned to Enzymatics, Inc.
  • Publication number: 20220411996
    Abstract: The invention provides fabrics that incorporate a cold-adapted trypsin derived from a fish or a crustacean, which trypsin inactivates viruses. The fabrics of the invention may be used in the production of various items of self-sterilizing protective equipment including gowns, sheets, curtains, surgical hats, surgical booties and protective facemasks.
    Type: Application
    Filed: August 28, 2022
    Publication date: December 29, 2022
    Applicant: Wabeso Enhanced Enzymatics, Inc
    Inventor: Mandy Jane Ward
  • Patent number: 11441261
    Abstract: The invention provides fabrics that incorporate protease enzymes that inactivate viruses and bacteria. The fabrics of the invention may be used in the production of various items of self-sterilizing protective equipment including protective facemasks.
    Type: Grant
    Filed: September 6, 2021
    Date of Patent: September 13, 2022
    Assignee: WABESO Enhanced Enzymatics, Inc.
    Inventor: Mandy Jane Ward
  • Patent number: 5278079
    Abstract: A channel or chamber device having means for inhibiting flow of aqueous medium therein after the channel or chamber has been filled with aqueous medium. The device has a channel or chamber with a sample intake port at one end and an exhaust port at the other end. A restricted or reduced size chamber portion having reduced dimension (height, cross-sectional area or diameter) toward the exhaust port is provided with a water-expandable polymer in the restricted or reduced size chamber portion. The water-expandable polymer inhibits flow or forms a seal in the exhaust port when the polymer is contacted with an aqueous medium. The channel or chamber device having means for inhibiting flow of aqueous medium therein is especially adaptable to capillaries used in medical diagnostic measuring devices which contain an analytical reagent for biological fluids, such as saliva and plasma.
    Type: Grant
    Filed: September 2, 1992
    Date of Patent: January 11, 1994
    Assignee: Enzymatics, Inc.
    Inventors: Julian Gubinski, John L. Palmer
  • Patent number: 5126247
    Abstract: Oxygen-independent methods, systems and devices for the enzymatic colorimetric assay and detection of biochemical analytes. Two systems are described, both of which produce less than one equivalent of dye per equivalent of substrate, maintaining dye concentrations in the range where Beer's law predicts a linear color-concentration relationship. One system produces an analog color signal from an analog analyte input, the other system produces a digital color signal from an analog analyte input.
    Type: Grant
    Filed: February 26, 1988
    Date of Patent: June 30, 1992
    Assignee: Enzymatics, Inc.
    Inventors: John L. Palmer, James B. Johnston, Marsha W. Timmerman
  • Patent number: 5112741
    Abstract: The invention provides a reagent system for the enzymatic determination of an oxidizable substrate in a fluid sample; the system includes an active amine trap for inactivating high concentrations of aldehyde and ketone oxidation products comprising a combination of at least one primary amine and at least one alpha-effect amine. An example of the oxidizable substrate is alcohol.
    Type: Grant
    Filed: July 7, 1988
    Date of Patent: May 12, 1992
    Assignee: Enzymatics, Inc.
    Inventors: John L. Palmer, Marsha W. Timmerman, Stephan D. Daubney
  • Patent number: 5036000
    Abstract: A system for quantitative colorimetric analysis of biological fluids or organic compounds, including NAD(P)H, or a substrate of an enzyme which reacts with the formation or consumption of NAD(P)H. Concentrations of organic substrates for example alcohol, cholesterol, uric acid, in a biological fluid such as saliva, blood or urine may be determined. The system gives a digital reading of the organic material the concentration which is sought to be determined; the concentration of NAD(P)H is determined by a color change or color "signal" when the NAD(P)H is above a threshold concentration and by the absence of a color signal when the concentration of NAD(P)H is below the threshold concentration. The system includes a chromogen, an electron-accepting reactant which, until exhausted, prevents a visible color change due to accumulation of reduced chromogen, and a catalyst.
    Type: Grant
    Filed: July 20, 1987
    Date of Patent: July 30, 1991
    Assignee: Enzymatics, Inc.
    Inventors: John L. Palmer, Marsha W. Timmerman
  • Patent number: 5032506
    Abstract: An assay system useful for the determination of NAD(P)H, NAD(P), or a substrate of an enzyme which reacts with the formation or comsumption of NAD(P)H. Concentrations of organic substrates for example alcohol, cholesterol, uric acid, in a biological fluid such as saliva, blood or urine may be determined. The system includes a diaphorase which catalyzes a NAD(P)H-dependent reduction of a chromogen to cause a visible color change; this color change is indicative of the concentration sought to be determined. The system includes a chromogen which is a first substrate for the diaphorase which causes a color change when reduced by NAD(P)H, and a second substrate which is a competing substrate for the diaphorase; the competing substrate is irreversibly reduced by the diaphorase. The system is capable of measuring colorimetrically without dilution concentrations of organic compounds in biological fluids which previously could not be measured in such concentration.
    Type: Grant
    Filed: December 16, 1986
    Date of Patent: July 16, 1991
    Assignee: Enzymatics, Inc.
    Inventors: John L. Palmer, Marsha W. Timmerman